Pfizer Net Worth 2006-2021 | PFE

Interactive chart of historical net worth (market cap) for Pfizer (PFE) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Pfizer net worth as of September 17, 2021 is $249.33B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $249.329B $41.908B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $434.939B 18.10
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Novo Nordisk (NVO) Denmark $241.084B 33.46
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
Bayer (BAYRY) Germany $52.972B 7.13
H Lundbeck (HLUYY) Denmark $5.383B 10.32
Innoviva (INVA) United States $1.059B 5.69